Research & Development

开心五月丁香五月五月婷婷申万:反弹进入“垃圾时间” 或未结束但已无关胜负


  這是國力強盛的最主要標志。   實在是疲憊了,這才會跳上馬車,跟父親擠在一起。开心五月   這兩者相輔相成,只要一以貫之的施行這樣的法度,大力禁止蓄奴之事發生。丁香五月   一個赤裸著上身,站在熱水鍋邊上繅絲的婦人,很可能就是長安某座鋪面的主人。   原本以為,皇帝會啟用他們這樣的降將帶領族人來填充這個空白。五月婷婷   上林苑也有窮人,可是,上林苑的窮人跟這里的窮人根本就是兩回事。

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo